Theravance Biopharma, Inc. (TBPH)
18.79
+0.61
(+3.36%)
USD |
NASDAQ |
Dec 19, 16:00
18.78
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Shareholders Equity (Annual): 175.54M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 679.59M |
| Perspective Therapeutics, Inc. | 290.67M |
| Skye Bioscience, Inc. | 68.15M |
| FibroGen, Inc. | -225.60M |
| Myomo, Inc. | 24.71M |